Voleni 2.0 · 2027
New formats.
Same standard.
In 2027, Voleni expands beyond flower. We are introducing our own-brand medical cannabis vape cartridges and pastille gummies, formulated, packaged and supplied for the UK medical market under the same Value · Core · Craft promise.
Format 01 · Vape cartridges
Voleni Vapour.
A 510-thread medical cannabis cartridge engineered for fast onset, repeatable dosing and the cleanest possible delivery. Filled with single-strain distillate from our Canadian and South African cultivars and reformulated for medical patients.
Pure distillate
Single-strain medical distillate, terpene-true to the source cultivar.
Ceramic core
Lead-free ceramic heating element for clean, consistent vapour.
Three strengths
Indica, sativa and balanced hybrid options across the patient spectrum.
Pharmacy ready
Tamper-evident, child-resistant packaging built for UK dispensary supply.
600mg
THC
200mg
CBD
510-thread
Cartridge
Format 02 · Pastille gummies
Voleni Pastilles.
A precisely dosed medical cannabis pastille for patients who need a discreet, oral format. Long onset, long duration, suited to chronic pain, sleep and patients stepping down from flower-based therapy.
Precise dosing
5mg THC + 5mg CBD per pastille, laboratory-verified for repeatable medical use.
Plant derived
Made with full-spectrum medical cannabis extract, no synthetic cannabinoids.
Discreet format
Sugar-free, gelatin-free pastilles suitable for daytime and long-term patients.
GMP produced
Manufactured in EU-GMP facilities under full pharmaceutical traceability.
5mg
THC
5mg
CBD
30
Per jar
2027 roadmap
From formulation to pharmacy.
- 01
Q1 2027
Formulation locked
Final distillate and pastille recipes signed off with our EU-GMP manufacturing partner.
- 02
Q2 2027
Regulatory dossier
MHRA Schedule 2 documentation and import licensing complete.
- 03
Q3 2027
Pilot dispense
First UK pharmacy and clinic pilots with selected prescribing partners.
- 04
Q4 2027
Full launch
National rollout across the Voleni pharmacy network: flower, vape and pastille.
- 01
Q1 2027
Formulation locked
Final distillate and pastille recipes signed off with our EU-GMP manufacturing partner.
- 02
Q2 2027
Regulatory dossier
MHRA Schedule 2 documentation and import licensing complete.
- 03
Q3 2027
Pilot dispense
First UK pharmacy and clinic pilots with selected prescribing partners.
- 04
Q4 2027
Full launch
National rollout across the Voleni pharmacy network: flower, vape and pastille.
Voleni 2.0
Flower, vapour, pastille.
All Voleni.
Same sourcing principles. Same quality framework. Same patient focus, extended into the formats UK clinicians are asking for.